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Validation of internal control genes for gene expression analysis
in diabetic glomerulosclerosis
JASON BIEDERMAN, JERRY YEE, and PEDRO CORTES
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan

Validation of internal control genes for gene expression analysis
in diabetic glomerulosclerosis.
Background. Gene expression analysis is an invaluable tool
in the study of diabetic glomerulosclerosis. The necessary denominator for the quantitative expression of a specific gene is
the expression level of a second gene that is presumed to remain
unchanged. Thus, it is critical that the stability of this housekeeping gene in diabetic glomeruli or in cultured glomerular cells is
not altered by the disease or a high glucose environment, respectively. Although gene expression quantification, achieved
by Northern blot analysis or real-time reverse transcriptionpolymerase chain reaction (RT-PCR) has been extensively applied in diabetic renal tissue in vivo and in vitro, there are no
studies validating the use of any specific endogenous control
gene in these measurements.
Methods. We performed real-time RT-PCR using RNA from
microdissected diabetic glomeruli and from mesangial cells
cultured in high glucose concentration to investigate gene expression stability of b-actin, glyceraldehyde-3-phosphate dehydrogenase (GADPH), phospholipase A 2 , b 2 -microglobulin,
acidic ribosomal protein 36B4, and cyclophilin A.
Results. Using an analysis method which is independent of
gene abundance and compares the pair-wise variation of a given
housekeeping gene with all other control genes, b-actin and
phospholipase A 2 , were found to be the most stable genes in
diabetic glomeruli and in primary mesangial cells exposed to
20 mmol/L glucose.
Conclusion. It is proposed that the expression level of these
genes is the best reference to evaluate relative changes in gene
activity in diabetic/high glucose exposed glomerular tissues.

Gene expression analysis is integral to unraveling the
pathophysiology of diabetic nephropathy and particularly diabetic glomerulosclerosis. Common techniques
include Northern blot analysis and real-time, reverse transcription-polymerase chain reaction (RT-PCR)
which has become popular due to its ability to quantify genes in small quantities of tissue. Quantification

is usually achieved by expressing the abundance of the
gene of interest relative to that of an internal control
gene, known as a housekeeping gene, which by necessity should not change under the experimental conditions
(e.g., diabetes). Commonly used housekeeping genes in
gene expression analyses of diabetic glomerulosclerosis have included glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-actin [1–11]. Surprisingly, there
are few studies validating the stability of genes used as
endogenous controls in kidney diseases and none that
address this critical issue in diabetic glomerulopathy [12,
13]. We performed real-time, RT-PCR on RNA extracted
from glomeruli microdissected from control and diabetic
Munich-Wistar rats and from primary mesangial cells
chronically exposed to 5 mmol/L and 20 mmol/L glucose
to quantify the expression of b-actin, GAPDH, tyrosine 3monooxygenase/tryptophan 5-monooxygenase activation
protein zeta polypeptide, also known as phospholipase
A 2 (YWHAZ), b 2 -microglobulin (b 2 M), acidic ribosomal protein 36B4 (36B4), and cyclophilin A (CycA). Each
of these genes has been used as an endogenous control
previously and many have been studied as potential references in nonrenal tissue [12–18]. The amount of total
RNA used as template was also included as a possible
reference of gene expression. The most stable internal
control genes were identified using the GeNorm software, which applies a measure of gene-stability that is
unaffected by gene abundance and does not require normalization [13].
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METHODS
Materials
Streptozotocin, dextran T-40, ribonucleoside vanadyl
complex, and the total glycated hemoglobin kit (TGHb
kit #442) were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). Isofluorane (Forane ) was obtained
from Baxter (Deerfield, IL, USA). Ambion (Austin, TX,
USA) supplied the RNase inhibitor SUPERaseIN. Qiagen Inc. (Valencia, CA, USA) provided the following
kits for mRNA purification and quantification: RNeasy
Mini Kit, RNase-free DNase Set, and Quantitect Probe
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RT-PCR Kit. Primers and probes were purchased from
TIB-Molbiol LLC (Adelphia, NJ, USA). Tissue culture
flasks (75 cm2 ) were obtained from Corning Inc. (Corning, NY, USA). RPMI 1640 culture medium and fetal
bovine serum (FBS) were obtained from Gibco BRL
(Grand Island, NY, USA).
Animals
Simonsen Laboratories (Gilroy, CA, USA) supplied
the animals. Studies were carried out according to protocols approved by the Institutional Animal Care and
Use Committee of Henry Ford Health Sciences Center. Insulin-deficient diabetes was induced in 14 male
Munich-Wistar rats at age 4 to 5 weeks old by a single
intravenous dose of 55 mg/kg streptozotocin, dissolved
in sodium citrate buffer-acidified normal saline, via the
dorsal penile vein. Fourteen control animals received the
same volume of solution vehicle. Postprandial (morning)
blood glucose measurements were obtained twice weekly
for 2 weeks then once every 3 to 4 weeks during the rest
of the study. A blood sample was obtained for determination of glycosylated hemoglobin at the completion of
the observation period.
Glomerular microdissection
After 22 weeks following streptozotocin injection,
glomeruli were microdissected from the left renal cortex
for isolation of total RNA, according to a modification
of a previously described method [19]. Following isofluorane/oxygen anesthesia, retrograde perfusion of the left
kidneys with 50 mL of ice-cold Hank’s balanced salt solution (HBSS) containing 3.2% dextran T40 was carried
out via a needle placed in the abdominal aorta below
the renal arteries, while the organ was externally cooled
with ice-cold 0.15 mol/L NaCl. Sagittal slices from the
left kidney were made and placed in 0.8 lm pore filtered
ice-cold HBSS, containing 5% ribonucleoside vanadyl
complex. A total of 160 glomeruli were microdissected
in less than 25 minutes and transferred into 50 lL of sterile phosphate-buffered saline (PBS) containing 2 U/lL of
RNase inhibitor. Following the addition of 350 lL of lysis buffer (buffer RLT) (RNeasy Mini Kit) samples were
rapidly homogenized with two 15 second bursts using a
rotor-strator homogenizer fitted with a 5 mm diameter
probe (Omni lH Micro Homogenizer) (Omni International Inc., Warrenton, VA, USA) and stored at −70◦ C.
Total glomerular RNA was isolated from glomerular
homogenates using the Qiagen’s RNeasy Mini Kit, according to the manufacturer’s instructions. This isolation
included an on-column DNase digestion step. Five microliters of isolated RNA from each of the 14 individual
glomerular preparations in each group was pooled. RNA
was stored at −70◦ C until RT-PCR was performed.
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Cell culture
Primary cultures of mesangial cells were obtained from
outgrowths of isolated glomeruli from Munich-Wistar
rats as previously described [20]. Cells were grown in
75 cm2 culture flasks in RPMI 1640 medium, pH 7.4
containing 5 Mmol/L glucose, 2 mmol/L L-glutamine,
23.8 mmol/L NaHCO 3 , 15% fetal bovine serum (FBS),
5 U/mL penicillin G, and 5 U/mL streptomycin. Culture
medium was changed at 2- or 3-day intervals. When reaching confluency at 10 days of growth, cells were reseeded
at 150 × 103 per flask. Eight weeks before the termination of the experiments the medium in the experimental group was changed to a similar medium containing
20 mmol/L glucose, while the control group was continuously grown in 5 mmol/L glucose. At the 12th passage,
cultures were harvested and total RNA isolated when
90% to 100% confluent using Qiagen’s RNeasy Mini Kit.
This included the addition of 700 lL of lysis buffer (buffer
RLT) (RNeasy Mini Kit) to each flask followed by homogenization as above. An on-column DNase digestion
step was again included and RNA stored at −70◦ C until
RT-PCR was performed.
Total RNA quantification
Total RNA was quantified using the RiboGreen RNA
Quantitation Kit (Molecular Probes Inc., Eugene, OR,
USA) which uses 16S and 23S ribosomal RNA as its RNA
standard. Samples were analyzed in triplicate using the
Fluoroskan Ascent FL (Thermo Electron Co., Milford,
MA, USA) microplate fluorimeter.
Quantitative real-time RT-PCR
Rapid cycle, real-time quantitative RT-PCR was carried out using the Roche LightCycler (Roche Molecular
Biochemicals, Indianapolis, IN, USA). In this method, a
one-step protocol was performed with the RT and PCR
reactions carried out sequentially in the same reaction
capillary. A commercially available reaction mix was used
(QuantiTectTM Probe RT-PCR) and RT-PCR was performed according to the manufacturer’s instructions (Qiagen) using 2 lL of sample RNA, 1 lmol/L primer, and
0.3 lmol/L probe. The housekeeping gene of interest
was amplified, following the RT reaction, with specific
primers and the quantity of product formation detected
by fluorescence resonance energy transfer (FRET) reactions using sequence-specific pairs of hybridization
probes labeled with fluorescein and an acceptor dye (LCRed 705). Conditions of RT-PCR included 30 minutes
reverse transcription at 50◦ C, 15 minutes polymerase activation at 95◦ C, and 35 cycles at 95◦ C for 0 seconds,
annealing at optimal temperature for 40 seconds, and
extension at 72◦ C for 40 seconds. Primers, probes, and
the experimentally determined annealing temperature
for each gene are listed in Table 1. All primers were specif-
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Table 1. Primers, probes, and experimentally determined optimal annealing temperature (T A ) used to determine housekeeping gene expression
Forward Primer
Reverse Primer
Donor Probe
Acceptor Probe
b-actin

Cyclophilin A (CycA)

Phospholipase A 2 (YWHAZ)

Acidic ribosomal phosphoprotein 36B4

Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)

b 2 -microglobulin (b 2 M)

TA

ACCCACACTgTgCCCATCTA
ggCCATCTCTTgCTCgAA
gCCACgCTCggTCAggATCTTCAT X
LC705 AggTAgTCTgTCAggTCCCggCCA p
TACCTACATTCCAAgCCTgC
CACCAgTgAgCTTCCTgC
TgCCgTCTTTCACCTTCCCTAAg X
LC705 CCACAACATgAAAgCCATCTgACC p

58◦ C

TggTgATgACAAgAAAgggA
TgTATCAAgTTCAgCAATggC
AACCAACACATCCTATCAgACTggg X
LC705 CTggCCCTTAACTTCTCTgTgTTCTA p
ggCATCACCACTAAAATCTCCA
CCAgTgggAAggTgTAgTCAg
TCCCACCTTgTCTCCAgTCTTTATCAgC X
LC705 gCACATCgCTCAggATTTCAATggT p
CTCCCTCAAgATTgTCAgCAA
GTCAgATCCACAACggATACATT
ACAgTCTTCTgAgTggCAgTgATggCA X
LC705 ACTgTggTCATgAgCCCTTCCACgAT p
TgCCATTCAgAAACTCCC
TTCAgTgTgAgCCAggATgT
CTATCTgAggTgggTggAACTgAgAC X
LC705 CgTAgCAgTTgAggAAgTTgggCTT p

50◦ C

ically designed for intron-exon splice regions thereby preventing any possible genomic DNA amplification. After
optimal RT-PCR conditions for each gene were determined, the resultant reaction products were separated
electropheretically using a 1.5% agarose gel for verification by size with an appropriate DNA ladder. As controls,
a sample with all reagents except RNA and a sample,
including all reagents except reverse transcriptase, were
included. Values were calculated as arbitrary units according to results from standard curves generated with
total renal cortex RNA. Individual template concentrations of five-point standard curves were measured in triplicate with each real-time RT-PCR assay. Equal amounts
of RNA, obtained from glomerular isolates in 14 individual control or diabetic animals, were pooled and measured in quintuplet. Their mean values were used in the
GeNorm analysis. Similarly, equal amounts of total RNA,
isolated from two 7 × 106 primary mesangial cell cultures
grown in 5 mmol/L or 20 mmol/L glucose, were pooled.
These pools were again measured in quintuplet and their
mean values used in the GeNorm analysis. As for the isolated glomeruli, a full standard curve was also analyzed
with each mesangial cell real-time RT-PCR assay.
Data analysis
Characteristics of control and diabetic rats were expressed as mean ± SE. Statistical significance of differences between means was determined by unpaired t test

60◦ C

58◦ C

58◦ C

60◦ C

and the distribution of t in a two-tailed test. P values less
than 0.05 were considered significant.
To determine the stability of endogenous control genes,
analysis was performed using the GeNorm 3.3 visual
basic application for Microsoft Excel (http://medgen31.
ugent.be/jvdesomp/genorm/) validated previously [13].
Briefly, this method is based on the principle that the expression ratio of two ideal control genes should be identical in all samples and unchanged by the experimental
conditions. An increase in the ratio variability represents
decreased expression stability of one, or both, of the genes
being evaluated. The program calculates the standard
deviation of log-transformed control gene ratios. These
ratios do not require normalization or equality of statistical variance making them strongly representative of the
variation between two control genes. The ratios are also
independent of differences in gene abundance and are
equally affected by outlying ratios. The GeNorm software
calculates the gene-stability measure (M) by determining
the average pair-wise variation between a particular gene
and all other control genes. By stepwise exclusion of the
least stable gene (highest M value) and recalculation of
M values after each exclusion, the two most stable genes
are identified.
RESULTS
Diabetic rats had elevated blood glucose (control 75 ±
2 mg/dL, diabetic 461 ± 22 mg/dL) (P < 0.0001) and
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Table 2. Relative abundance of gene specific mRNA as quantified by real-time reverse transcription-polymerase chain reaction (RT-PCR) for
microdissected glomeruli and primary mesangial cells listed from most abundant to least abundant (top to bottom)
Control microdissected
glomeruli arbitrary unitsa

Gene
b-actin
Phospholipase A 2 (YWHAZ)
b2-microglobulin (b 2 M)
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
Acidic ribosomal phosphoprotein 36B4
Cyclophilin A (CycA)
a

22.3
16.5
12.0
6.4
5.1
1.0

Gene
b-actin
Phospholipase A 2 (YWHAZ)
Acidic ribosomal phosphoprotein 36B4
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
b2-microglobulin (b 2 M)
Cyclophilin A (CycA)

Control primary mesangial
cells arbitrary unitsa
20.7
18.6
11.7
11.6
7.0
1.0

Results are expressed relative to cyclophilin A (least abundant gene).

Table 3. Internal control genes ranked from most stable expression
(top) to least stable expression (bottom) in RNA samples from
control and diabetic microdissected glomeruli and from primary
mesangial cells cultured in 5 mmol/L or 20 mmol/L glucose

Average expression stability, M

A
0.8
0.6

Microdissected glomeruli
b-actin, phospholipase A 2
(YWHAZ)
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
Acidic ribosomal phosphoprotein
36B4
b2-microglobulin (b 2 M)

0.4
0.2
0
CycA Total RNA B2M

36B4 GAPDH b-actin,
YWHAZ

Average expression stability, M

B
0.3

0.2

0.1

0
B2M

CycA GAPDH 36B4 Total RNA b-actin,
YWHAZ

Fig. 1. Expression stability of internal control genes using the GeNorm
expression analysis software, plotted from least stable to most stable
(left to right). (A) Pooled samples of microdissected glomerular RNA
from control and diabetic rats (160 glomeruli/animal). (B) RNA extracted from primary mesangial cells cultured for 8 weeks in 5 mmol/L
or 20 mmol/L glucose.

increased glycated hemoglobin (control 5.4 ± 0.4%, diabetic 11.8 ± 0.4%) (P < 0.0001) as compared to controls.
Diabetic animals had less weight gain than controls resulting in lower final weight (control 349 ± 6 g, diabetic
265 ± 10 g) (P < 0.0001).
RT-PCR results of RNA standards yielded linear timecycle/log concentration regressions for all genes, with
correlation coefficients of 0.98 or greater and standard

Total RNA
Cyclophilin A (CycA)

Primary mesangial cells
b-actin, phospholipase A 2
(YWHAZ)
Total RNA
Acidic ribosomal
phosphoprotein 36B4
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
Cyclophilin A (CycA)
b2-microglobulin (b 2 M)

errors below 0.12. The housekeeping genes selected
demonstrated a wide variation in their expression levels
(Table 2). The GeNorm analysis demonstated a greater
overall stability of internal control gene expression in cultured mesangial cells than in microdissected glomeruli
(Fig. 1). b-actin and YWHAZ offered the most stable expression in diabetic microdissected glomeruli as well as
in primary mesangial cells cultured in 20 mmol/L glucose
(Table 3). For the purpose of illustration, Tables 4 (isolated glomeruli) and 5 (cultured mesangial cells) contain
the relative expression ratios, prior to log-transformation,
of the two extremes of control gene stability as compared
to the rest of the endogenous controls tested.
Total RNA concentration in the specimens was
6.3 ng/lL and 7.7 ng/lL in the pooled control and diabetic glomeruli, respectively. In the samples of primary
mesangial cells cultured in 5 mmol/L and 20 mmol/L
glucose, the corresponding concentrations of total RNA
were 194 ng/lL and 208 ng/lL, respectively. In glomerular
samples, total RNA template used in the reaction was a
poor marker for endogenous control gene stability while
in primary mesangial cells, total RNA correlated reasonably well with stability of housekeeping gene expression
(Fig. 1).
DISCUSSION
Enhanced expression of multiple genes is expected
in diabetes and after exposure to a high glucose
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Table 4. Relative expression ratios for the best [b-actin and phosholipase A 2 (YWHAZ)] and worst [cyclophilin A (CycA)] internal control genes
prior to log-transformation using total RNA isolated from control and diabetic microdissected glomeruli (the ratio between two ideal endogenous
controls should be identical across treatment groups)

Control
Diabetes
% difference

Control
Diabetes
% difference

Control
Diabetes
% difference

b-actin:
YWHAZ

b-actin:glyceraldehyde3-phosphate
dehydrogenase (GAPDH)

b-actin: Total RNA

b-actin:acidic
ribosomal
phosphoprotein 36B4

b-actin:b2microglobulin
(b 2 M)

1.35
1.43
5.9%
YWHAZ:b-actin

3.45
3.20
8.0%
YWHAZ: GAPDH

0.87
1.53
43.5%
YWHAZ: Total RNA

4.40
3.04
44.9%
YWHAZ:36B4

1.85
1.27
45.8%
YWHAZ:b 2 M

YWHAZ:CycA

0.74
0.70
6.3%
CycA:b 2 M

2.57
2.23
14.8%

0.64
1.07
39.9%

3.27
2.12
53.9%

1.37
0.89
54.9%

16.6
2.99
456%

CycA:36B4

CycA: GAPDH

CycA:b-actin

0.08
0.30
72.1%

0.20
0.71
72.3%

0.15
0.75
79.3%

0.04
0.23
80.9%

b-actin:CycA
22.4
4.27
423%

CycA:YWHAZ CycA:Total RNA
0.06
0.33
82.0%

0.04
0.35
89.2%

Table 5. Relative expression ratios for the best [b-actin and phospholipase A 2 (YWHAZ)] and worst b 2 -microglobulin (b 2 M)] internal control
genes prior to log-transformation using total RNA isolated from primary mesangial cells cultured in 5 mmol/L and 20 mmol/L glucose (the ratio
between two ideal endogenous controls should be identical across treatment groups)
b-actin:
b-actin: glyceraldehydeacidic ribosomal
3-phosphate
phosphoprotein 36B43 dehydrogenase (GAPDH)

b-actin:
cyclophilin
A (CycA)

b-actin:b 2 M

b-actin: YWHAZ

b-actin: Total RNA

5 mmol/L
20 mmol/L
% difference

1.11
1.13
1.9%
YWHAZ:b-actin

0.063
0.062
2.2%
YWHAZ: Total RNA

1.77
1.95
9.5%
YWHAZ:36B4

1.78
1.49
19.2%
YWHAZ:GAPDH

0.21
0.27
24.3%
YWHAZ:CycA

2.97
4.43
33.0%
YWHAZ:b 2 M

5 mmol/L
20 mmol/L
% difference

0.90
0.88
1.9%

0.057
0.054
4.1%

1.59
1.72
7.7%

1.60
1.32
21.5%

0.19
0.24
22.9%

2.67
3.91
31.7%

b 2 M:CycA

b 2 M:36B4

b 2 M:YWHAZ

b 2 M:b-actin

0.070
0.062
12.9%

0.60
0.44
35.1%

0.37
0.26
46.4%

0.34
0.23
49.1%

5 mmol/L
20 mmol/L
% difference

environment as a result of glomerular cell hypertrophy
[21–23]. The imperative question is if there is differential
expression among some of these genes. Investigators have
demonstrated changes in expression patterns among several genes believed to be involved in the development of
diabetic glomerulopathy, including transforming growth
factor-b (TGF-b), Smad3, fibronectin, type IV collagen,
and monocyte chemoattractant protein-1 (MCP-1) [1–11].
We present herein the first validation of endogenous control genes used to measure the relative expression of these
pathogenetically relevant genes.
Vandesompele et al [13] analyzed several internal control genes including GAPDH, b 2 M, b-actin, and YWHAZ by RT-PCR in various human tissues. Importantly,
they developed and validated the GeNorm analysis software used herein to analyze the stability of housekeeping
genes without prior knowledge of the amount of starting
RNA by calculating the standard deviation of the logtransformed control gene ratios. This logarithmic transformation is necessary to control for possible outlying
values and differences in gene abundance.

b 2 M: Total RNA b 2 M:GAPDH
0.021
0.014
52.4%

0.60
0.34
77.9%

YWHAZ was found to be a robust endogenous control gene in human leukocyte samples but not as stable
in other human tissues by Vandesompele et al [13]. Their
analysis did not include kidney tissue or cultured renal
cells. b-actin has been used as an internal control gene
for gene expression analysis by investigators studying diabetic nephropathy [2, 6, 8]. Whereas b-actin was shown
to have stable expression in human skeletal muscle, this
stability could not be duplicated in adipose or colonic
tissue, emphasizing the necessity to validate endogenous
controls in different tissues [14–16].
Here it is shown that, in primary mesangial cells exposed to a high glucose environment, while b-actin and
YWHAZ were the best internal control genes, all of the
genes studied appeared relatively stable as represented
by their low M values, the marker of gene stability. In contrast, results in microdissected glomeruli showed variable
expression stability of internal control genes. Our analysis
found YWHAZ and b-actin had the most stable expression in diabetic glomeruli. To illustrate the significance of
housekeeping gene expression variability, analysis of the
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relative expression ratios of the two most and the least
stable endogenous control genes was carried out prior to
logarithmic transformation. As an example, in cultured
primary mesangial cells (Table 5), the use of a robust
housekeeper like YWHAZ or b-actin would result in a
2% error in the differential expression of a given gene by
the high glucose environment. Use of a less stable gene
like GAPDH would result in 19% variation whereas use
of b 2 M would yield a 33% error. Stated another way, using b 2 M to normalize gene expression changes caused by
high glucose would overestimate the target gene expression by one third. Similarly, use of CycA as the denominator for gene quantification in diabetic isolated glomeruli
would underestimate the expression of the gene of interest by fourfold (Table 4). These results were determined
using real-time RT-PCR and therefore extrapolation to
other gene expression techniques (e.g., quantitative competitive PCR, semiquantitative PCR, or Northern blot
analysis) may not be appropriate.
In our analysis, the most abundant genes generally displayed the least variability in gene expression induced by
the high glucose state. This is not entirely surprising since
a small quantitative change in gene expression induced by
high glucose may have an apparent smaller overall effect
on a gene already expressed in large quantities at baseline
as compared to one expressed in small quantities.
Schmid et al [12] recently published an analysis of
CycA, GAPDH, and 18S rRNA as endogenous controls for microdissected human renal biopsy tissue. They
found a high degree of correlation between CycA and
18S rRNA in the tubulointerstitial compartment. However, GAPDH correlated poorly with 18S rRNA in both
glomerular and tubulointerstitial compartments. In this
study, we have demonstrated CycA to be a poor reference gene in microdissected diabetic glomeruli. Similar
to the results of Schmid et al in other tissues, we also
found GAPDH to be a poor reference in microdissected
glomeruli. In contrast, GAPDH has been demonstrated
to be a stable endogenous control gene in human leukocytes, bone marrow, and adipocytes [13, 16].
The acidic ribosomal protein 36B4 has been used as
an internal control gene in the breast cancer cell line
MCF-7 [17, 18]. However, Gorzelniak et al [16] demonstrated variable expression of this protein in adipocytes
and preadipocytes. Similarly, our results show 36B4 to be
a suboptimal housekeeping gene in diabetic glomeruli. In
addition, we also found b 2 M to be a poor internal control
gene for gene expression analysis in glomeruli and mesangial cells. Studies in human skeletal muscle, adipocytes,
pooled human tissue, and several human cell lines have
similarly demonstrated variable behavior [13, 14, 16].
Finally, while total RNA was a stable parameter for reference in tissue culture it varied in glomeruli. Total RNA
primarily consists or rRNA but it has been suggested to
be unsuitable as an endogenous control because of im-
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balances between the rRNA and mRNA fractions [13].
Hence, using the amount of total RNA template added
to the RT-PCR reaction as the denominator for normalization of samples is not reliable in diabetic glomeruli.
Taken together these results show that the housekeeping genes of choice for analyzing relative gene expression in glomeruli from diabetic rats or primary mesangial
cells chronically exposed to high glucose are b-actin and
YWHAZ. This choice appears much more important for
glomeruli. As others have suggested, although not always
feasible, the expression data become much more robust
if expressed relative to two internal controls instead of
one [13]. Furthermore, if bioactive substances are tested,
it would be prudent to evaluate their effects on the stability of housekeeping gene-expression as part of the study
of diabetic animals.
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